Literature DB >> 16808901

Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.

Jennifer Apodaca1, Ikjin Kim, Hai Rao.   

Abstract

Secretory proteins undergo a stringent quality control process in the endoplasmic reticulum (ER). Misfolded ER proteins are returned to the cytosol and destroyed by the proteasome. Prion protein PrP is degraded by the proteasome in mammalian cells. However, the significance of proteolysis on PrP-induced cell death is controversial. Moreover, the specific pathway involved in PrP degradation remains unknown. Here, we demonstrate that the unglycosylated form of human PrP is subjected to the ER-associated protein degradation (ERAD) process in the yeast Saccharomyces cerevisiae. We also show that unglycosylated PrP is degraded by the Hrd1-Hrd3 pathway. Accumulation of misfolded proteins triggers the unfolded protein response (UPR), which promotes substrate refolding. Interestingly, we find that the expression of PrP leads to growth impairment in cells deficient in UPR and ERAD. These findings raise the possibility that decreased UPR activity and proteolysis may contribute to the pathogenesis of some prion-related diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808901     DOI: 10.1016/j.bbrc.2006.06.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

2.  Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay.

Authors:  Aleksandr A Rubel; Tatyana A Ryzhova; Kirill S Antonets; Yury O Chernoff; Alexey Galkin
Journal:  Prion       Date:  2013-10-23       Impact factor: 3.931

Review 3.  The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.

Authors:  G Michael Preston; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2017-02-15       Impact factor: 3.857

Review 4.  Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration.

Authors:  Roberto Bravo; Valentina Parra; Damián Gatica; Andrea E Rodriguez; Natalia Torrealba; Felipe Paredes; Zhao V Wang; Antonio Zorzano; Joseph A Hill; Enrique Jaimovich; Andrew F G Quest; Sergio Lavandero
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

5.  Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders.

Authors:  Mauricio Torres; Gonzalo Encina; Claudi Soto; Claudio Hetz
Journal:  Commun Integr Biol       Date:  2011-05

Review 6.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

7.  Analysis of quality control substrates in distinct cellular compartments reveals a unique role for Rpn4p in tolerating misfolded membrane proteins.

Authors:  Meredith Boyle Metzger; Susan Michaelis
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

Review 8.  Physiological and environmental control of yeast prions.

Authors:  Tatiana A Chernova; Keith D Wilkinson; Yury O Chernoff
Journal:  FEMS Microbiol Rev       Date:  2013-12-04       Impact factor: 16.408

9.  Familial prion protein mutants inhibit Hrd1-mediated retrotranslocation of misfolded proteins by depleting misfolded protein sensor BiP.

Authors:  Sarah L Peters; Marc-André Déry; Andrea C LeBlanc
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

10.  Usa1 protein facilitates substrate ubiquitylation through two separate domains.

Authors:  Ikjin Kim; Yue Li; Paulina Muniz; Hai Rao
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.